Artificial Intelligence (AI) describes programming computers to perform tasks that traditionally require human intelligence.
portfolio
Nestlé’s diversifying into health and wellness one to watch: Insync
“As the world’s largest food + beverage company, Nestlé, is now focusing on nutritional therapy, a diversification effort that taps into the fast-growing, high-margin healthcare product market,” said Mr Monik Kotecha, CIO, Insync Fund Managers. “Nestlé Management’s constant long-term focus on innovation and identifying/investing into the next megatrend has enabled it to deliver consistent revenue […]
The Silver Economy shines for long-term growth in portfolios
While Australians can invest in some excellent local healthcare companies, there are limitations. For instance, they tend to be either single or narrow product device companies, says Monik Kotecha, Insync. Global pharmaceutical companies benefit from ageing demographics By 2005, 10 per cent of global population was aged over 60 By 2050, 22 per cent of […]
Insync invests in global biotech company Thermo Fisher
Insync Global Titans Fund has invested in global biotechnology company Thermo Fisher Scientific on an attractive free cash flow yield of 5.7 per cent for 2016. Ageing populations, the need for better and broader healthcare access globally, more stringent environmental and testing regulations, along with the rising demand for better healthcare and a cleaner environment […]